Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Orthostatic; Hypotension, Parkinsonism”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableLooking for participantsNCT06920134
What this trial is testing

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

Who this might be right for
Hypotension SymptomaticParkinson's DiseaseOrthostatic Hypotension, Dysautonomic+2 more
Ecole Polytechnique Fédérale de Lausanne 5
Not applicableLooking for participantsNCT04782830
What this trial is testing

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

Who this might be right for
Orthostatic; Hypotension, NeurogenicAutonomic FailurePure Autonomic Failure+2 more
Vanderbilt University Medical Center 29
Not applicableNot Yet RecruitingNCT07322458
What this trial is testing

The Effect of Spinal Cord Stimulation on Orthostatic Hypotension in Parkinsonism and Its Related Mechanisms

Who this might be right for
Parkinsonism
Ruijin Hospital 40
Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Not applicableStudy completedNCT02021903
What this trial is testing

Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies

Who this might be right for
Parkinsonian Disorders
University Hospital, Toulouse 21
Large-scale testing (Phase 3)Study completedNCT05487300
What this trial is testing

Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease

Who this might be right for
Parkinson DiseaseOrthostatic Hypotension
University of Utah 40
Early research (Phase 1)Looking for participantsNCT02897063
What this trial is testing

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

Who this might be right for
Autonomic FailurePure Autonomic FailureMultiple System Atrophy+2 more
Vanderbilt University Medical Center 34
Testing effectiveness (Phase 2)Study completedNCT02705755
What this trial is testing

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Who this might be right for
Neurogenic Orthostatic HypotensionMultiple System Atrophy (MSA) With Orthostatic HypotensionPure Autonomic Failure+5 more
Theravance Biopharma 34
Not applicableStudy completedNCT01316666
What this trial is testing

Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension

Who this might be right for
Orthostatic HypotensionPure Autonomic FailureMultiple System Atrophy+1 more
Vanderbilt University Medical Center 50
Not applicableLooking for participantsNCT05400174
What this trial is testing

Blood Pressure Effects on Cognition and Brain Blood Flow in PD

Who this might be right for
Parkinson DiseaseOrthostatic HypotensionDysautonomia
University of California, San Diego 60
Testing effectiveness (Phase 2)UnknownNCT03567447
What this trial is testing

Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Parkinson DiseaseFalls Patient
St. Joseph's Hospital and Medical Center, Phoenix 10
Post-approval studies (Phase 4)Study completedNCT04510922
What this trial is testing

Lundbeck TOMs Orthostatic Hypotension

Who this might be right for
Orthostatic HypotensionIdiopathic Parkinson Disease
Alberto Espay, MD, MSc 9
Testing effectiveness (Phase 2)Study completedNCT01676103
What this trial is testing

The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease

Who this might be right for
Parkinson's Disease
New York Institute of Technology 40
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Large-scale testing (Phase 3)Ended earlyNCT03829657
What this trial is testing

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSAParkinson's Disease (PD)+1 more
Theravance Biopharma 203
Not applicableStudy completedNCT03900000
What this trial is testing

Improved Orthostatic Tolerance = Better Cognitive Function in Parkinson's Disease

Who this might be right for
Hypotension, OrthostaticParkinson DiseaseAutonomic Failure+1 more
RWTH Aachen University 30
Early research (Phase 1)Study completedNCT00103597
What this trial is testing

Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy

Who this might be right for
Parkinson's DiseaseMultiple System AtrophyOrthostatic Hypotension
Royal Brisbane and Women's Hospital 50
Not applicableNot Yet RecruitingNCT07139756
What this trial is testing

Deciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic Hypotension

Who this might be right for
Parkinson DiseaseOrthostatic Hypotension
Centre Hospitalier Universitaire Vaudois 130
Not applicableUnknownNCT04920552
What this trial is testing

Abdominal Binders to Treat Orthostatic Hypotension in Parkinsonian Syndromes

Who this might be right for
Parkinson DiseaseMultiple System Atrophy, Parkinson VariantOrthostatic; Hypotension, Neurogenic
Universitätsklinik für Neurologie, Innsbruck 30
Large-scale testing (Phase 3)Study completedNCT03750552
What this trial is testing

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 195
Load More Results